According to SLC6A1 mRNA expression, CRC patients in TCGA database were divided into SLC6A1 low expression group and SLC6A1 high expression group, and 42 differentially expressed genes between two groups were screened (Supplementary Table S2). This evidence concerns the gene SLC6A1 and colorectal carcinoma.